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Abstract
 
Telomeres shorten in hematopoietic cells, including hematopoietic stem cells (HSCs), during
aging and after transplantation, despite the presence of readily detectable levels of telomerase in
these cells. In T cells, antigenic stimulation has been shown to result in a marked increase in the
level of telomerase activity. We now show that stimulation of T cells derived from serially
transplanted HSC results in a telomerase-dependent elongation of telomere length to a size
similar to that observed in T cells isolated directly from young mice. Southern analysis of telo-
mere length in resting and anti-CD3/CD28 stimulated donor-derived splenic T cells revealed
 
an increase in telomere size by 
 
 
 
7 kb for the population as a whole. Stimulation of donor-
derived T cells from recipients of HSCs from telomerase-deficient mice did not result in regen-
eration of telomere length, demonstrating a dependence on telomerase. Furthermore, clonal
anti-CD3/CD28 stimulation of donor-derived T cells followed by fluorescent in situ hybrid-
ization (FISH) analysis of telomeric signal intensity showed that telomeres had increased in size
by 
 
 
 
50% for all clonal expansions. Together, these results imply that one role for telomerase in
T cells may be to renew or extend replicative potential via the rejuvenation of telomere length.
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Introduction
 
Telomeres are genetic elements that are essential for the sta-
bility of chromosomal ends. The critical shortening or loss
of one or more telomeres leads to the formation of unstable
end-to-end fusions and chromosomal instability (1–3).
Telomeric chromatin is composed of a number of different
telomeric binding proteins and tandem arrays of simple
DNA repeats, (TTAGGG)n in mammals (4) ranging in
length from 
 
 
 
100 bp in ciliates (5) to 5,000–8,000 bp in
humans (6–8) and, in some mouse strains, 
 
 
 
100,000 bp (9).
The telomerase complex, composed of an essential RNA
component (10) and several different protein components
including an essential catalytic component (11) is required
for the complete replication of telomeres in most dividing
eukaryotic cell populations (12). Immortal cell populations,
including germ line cells and tumor cell lines, express te-
lomerase and maintain a stable telomere length (2, 13–15).
Genetic ablation of the telomerase RNA gene in yeast (16)
and mouse embryonic stem cells (17) or inhibition of te-
lomerase in tumor cell lines (18) leads to the continuous
attrition of telomere length as cells divide, culminating in
growth arrest and/or cell death. Telomere length also
shortens during replicative aging in many types of human
somatic cells in which telomerase is repressed (2, 6, 7, 19).
Many mitotically active somatic cells in humans have a
finite replicative capacity, up to 
 
 
 
100 population dou-
blings (pd), when grown in vitro. The state of irreversible
growth arrest that subsequently ensues is termed replicative
senescence (20). Studies have now demonstrated that repli-
cative senescence is the ultimate effect of continuous telo-
mere attrition, as activation of telomerase via ectopic
expression of the catalytic component of telomerase, te-
lomerase reverse transcriptase (TERT;
 
*
 
 reference 11) in
primary cell strains prevents telomere shortening and leads
to cell immortalization (19, 21, 22).
A perplexing feature of hematopoietic cells, including
hematopoietic stem cells (HSCs), is the presence of readily
detectable levels of telomerase activity (23, 24) and yet di-
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vision of these cells, is accompanied by extensive telomere
shortening both in vitro (22, 25) and in vivo (8, 26, 27). It
has also recently been shown that the continuous erosion of
telomeres and limited replicative capacity observed in long
term cultures of T cells from humans (22, 25) can be pre-
vented by the ectopic expression of TERT (22, 28). Thus,
for reasons unknown at present, telomerase appears to be
present in hematopoietic cells, but not fully functional.
Recently, we have shown that telomere length shortens
in HSCs and other hematopoietic cells of donor type dur-
ing serial transplantation of HSCs in mice (27). We now
show that stimulation of splenic T cells isolated from HSC
transplant recipients results in a telomerase-dependent res-
toration of telomere length to a size found in young mice.
 
Materials and Methods
 
Mice.
 
The derivation of the mTR knockout mice and
mTERT knockout mice has been described previously (3, 29).
The mTR
 
 
 
/
 
 
 
 mice and mTERT
 
 
 
/
 
 
 
 mice were backcrossed 6
and 4 times, respectively, to the C57Bl/Ka-Thy1.1(Ly5.1) strain
at the Stanford University animal facility before use in this study.
In all transplant experiments, the Thy1.1/Ly5.1 mice were used
as HSC donors and the congenic C57Bl/Ka-Thy1.2(Ly5.2) strain
was used as recipients. The initial donor mice and all the recipient
mice were 2–3 mo old. The major histocompatibility class I gene
promoter (H2K
 
b
 
-GFP) transgenic mice colony was developed
and maintained at Stanford University. All mice were bred and
maintained on acidified water (pH 2.5).
 
HSC Detection and Transplantation.
 
Bone marrow cells were
isolated and stained with fluorophor-conjugated antibodies as de-
scribed previously (27). The antibodies used in the immunofluo-
rescence staining for HSC detection are as described previously
(27). The HSC population is defined as c-kit
 
hi
 
Sca-1
 
hi
 
Thy1.1
 
lo
 
lineage
 
 
 
. Whole bone marrow aliquots containing either
100 or 200 HSCs were used in each round of transplantation.
 
Splenic T Cell Sorting and Stimulation.
 
Spleens were collected
and single cell suspensions prepared followed by lysis of red
blood cells using ACK solution (150 mM NH
 
4
 
Cl, 10 mM
KHCO
 
3
 
). Splenocytes were stained with an antibody cocktail
(CD3
 
PE
 
, B220
 
APC
 
, Ly5.1
 
FITC
 
, and Ter119
 
TR
 
) in staining media
(Hank’s balanced salt solution plus 3% fetal bovine serum, pH
7.2) on ice for 30 min. Cells were then washed once and resus-
pended in staining media containing propidium iodide (0.5 
 
 
 
g/
ml). The donor type splenic T cells and splenic T cells from
H2K-GFP transgenic mice were defined as (CD3
 
hi
 
B220
 
 
 
Ly5.1
 
hi
 
Ter119
 
 
 
) and (CD3
 
hi
 
B220
 
 
 
), respectively, and
were purified by FACS
 
®
 
 on a dual-laser Vantage (Becton Dick-
inson) FACS
 
®
 
 machine. Cells were either sorted into growth
media (RPMI 1640 plus 10% FBS (GIBCO BRL), glutamine,
nonessential amino acids, Pen/Strep, sodium pyruvate, 
 
 
 
-mer-
captoethanol, mIl-2 (200 U/ml), and CD28 antibody [a kind gift
from Dr. Tien Chin, Department of Immunology, Stanford Uni-
versity]) in 24-well plates (mass culture) or 96-well V-bottom
plates (oligoclonal culture) precoated with CD3 antibody (BD
Biosciences). During oligoclonal culture, cells were split at a 1:2
ratio on days 7, 11, and 14, and donor-derived cells were har-
vested on day 17.
 
Detection of Telomerase Activity.
 
The TRAP assay and quanti-
fication of telomerase activity was performed using the TRAP as-
say kit from Intergen, as described (15) but with following modi-
fications. The final concentration for all dNTPs was 10 mM, and
0.2 
 
 
 
g of TS primer was used per 25 
 
 
 
l reaction.
 
DNA Isolation and Terminal Restriction Fragment Length Analysis
by Field Inversion Gel Electrophoresis.
 
Splenic T cells were col-
lected for DNA isolation at the time of the initial transplantation
and from secondary HSC transplant recipients 4 mo or more
post-transplant. The DNA was isolated, digested with restriction
enzymes, and subjected to southern analysis of terminal restric-
tion fragment (TRF) length using a field inversion gel electro-
phoresis
 
 (
 
FIGE) apparatus as described previously (27). Mean
TRF length was calculated as described previously (25).
 
Fluorescent In Situ Hybridization.
 
Cells were fixed and telo-
meres stained with a FITC conjugated peptide nucleic acid telo-
meric oligomer, (CCCTAA)
 
3
 
 (Applied Biosystems), as described
previously (27, 30). Images were collected and quantitative analy-
sis of the fluorescent signal intensity was performed using a
ZEISS confocal microscope. Control slides of unstained cells
were used to correct for background fluorescence.
 
Immunostaining.
 
The telomerase specific K-370 antibody was
used to detect mTERT as described previously (31). Briefly, cells
were fixed in methanol, blocked in 10% goat serum, and stained
with a 1/500 dilution of the K-370 antibody in 1% serum for 1 h
at 37
 
 
 
C. Cells were washed in PBS, and stained with biotin-con-
jugated anti–rabbit IgG (Vector Laboratories) for 1 h at 37
 
 
 
C. Af-
ter a brief wash in PBS, cells were stained with Texas Red-con-
jugated avidin (Sigma-Aldrich) for 1 h at 37
 
 
 
C. Nuclei were
stained with Hoechst 33258.
 
Results
 
Southern Analysis of Terminal Restriction Fragment Length in
Resting and Stimulated T Cells from HSC Recipients.
 
To as-
sess the effect on telomere length of antigenic stimulation
of T cells of donor type from adult mice and HSC trans-
plant recipients, we collected donor-derived splenic T cells
by FACS
 
®
 
 for anti-CD3/CD28 stimulation in vitro and
performed southern analysis of TRF length on the resting
and stimulated T cells (Fig. 1). The TRF length for resting
splenic T cells isolated from secondary HSC recipients
(mean 
 
 
 
16 kb) was significantly shorter than that observed
for resting T cells from young adult mice (mean 
 
 
 
23 kb;
P 
 
 
 
 0.005). 1 wk after anti-CD3/CD28 stimulation, no
change in the TRF length was detected for splenic T cells
isolated from young adult mice. However, the TRF length
of the stimulated splenic T cells isolated from HSC trans-
plant recipients had increased significantly (Fig. 1; P 
 
 
 
0.002), to an average size approximately equal to that ob-
served for splenic T cells from young adult mice.
 
Activation of Telomerase Is Required for Telomere Length In-
crease in Stimulated T Cells.
 
To assess the potential role of
telomerase in the restoration of telomere length in stimu-
lated T cells derived from transplanted HSCs, we per-
formed the TRAP assay on resting and anti-CD3/CD28
stimulated splenic T cells (Fig. 2). Similar to that reported
in previous studies (32–35), we observed a large (
 
 
 
45 fold;
Fig. 2 B) increase in telomerase activity 2 d after anti-CD3/
CD28 stimulation of donor-derived T cells from adult
mice and from HSC transplant recipients. No difference in
the level of telomerase activity was observed for resting T
cells or stimulated T cells isolated from young adult mice as 
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compared with secondary HSC recipients. To begin to as-
sess the mechanism as to how telomerase is activated after
antigenic stimulation of T cells, we stained splenic T cells
with an antibody to mTERT before and after anti-CD3/
CD28 stimulation. TERT appeared to be localized primar-
ily in the cytoplasm of resting cells and in the nucleus of
stimulated cells (Fig. 2 C), as previously observed by others
(36). To exclude the possibility of nonspecific binding of
the mTERT antibody, splenic T cells from mTERT
 
 
 
/
 
 
 
mice were also stained. Only a very faint, nonspecific nu-
clear signal was observed in both resting mTERT
 
 
 
/
 
 
 
 T
cells (Fig. 2 C) and activated mTERT
 
 
 
/
 
 
 
 T cells (data not
depicted).
To verify the essential role of telomerase in telomere
length rejuvenation after activation of T cells, we analyzed
telomere length in T cells from young adult mice and sec-
ondary HSC recipients in which the gene encoding the
RNA component of telomerase (mTR) was knocked out
(3). Telomere length was analyzed using fluorescent in situ
hybridization (FISH) as opposed to southern analysis of
TRF length due to the large, heterogeneous, multi-modal
nature of the TRFs in this mouse strain (unpublished data).
Telomere signal intensity increased after antigenic stimula-
tion of donor-derived T cells from secondary recipients of
HSC from mTR
 
 
 
/
 
 
 
 mice (Fig. 3; P 
 
  
 
0.001), in agree-
ment with the increase in TRF length observed for wild-
type C57Bl/Ka Thy1.1 mice (Fig. 1). However, no change
in telomere signal intensity was observed following stimu-
lation of donor-derived T cells from secondary recipients
of HSCs from mTR
 
 
 
/
 
 
 
 mice (Fig. 3), thereby confirming
the necessity of telomerase for extension of telomere
length.
 
Telomere Length Increase in Stimulated T Cells Is Due to
Elongation of Short Telomeres by Telomerase, Not Selection of
Cells with a Long Telomere Length.
 
The increase in telo-
mere size in stimulated splenic T cells isolated from HSC
transplant recipients could be accounted for by selection of
T cells with a long initial telomere length and/or the syn-
thesis of new telomeric DNA after stimulation of T cells
with a short initial telomere length. The former possibility
implies that there is a rare population of T cells with long
telomeres in the spleens of HSC transplant recipients. This
population must exist at a frequency of 
 
 
 
10% or less of the
reconstituted splenic T cells since we are able to detect two
distinct modes of longer and shorter TRFs when DNA
from splenic T cells of donor type from adult mice and sec-
ondary HSC transplant recipients are mixed at a ratio as
low as 1:10 and analyzed for TRF length, but only observe
Figure 1. Analysis of TRF length of resting and stimulated donor-
derived T cells. (A) Splenic T cells (5   104) from young adult mice and
secondary HSC recipients were collected via FACS® and either trans-
ferred to growth media for stimulation or used for isolation of high mo-
lecular weight DNA. Anti-CD3/CD28 stimulated T cells were collected
for isolation of DNA after 1–2 wk of growth. The extraction and restric-
tion enzyme digestion of DNA was performed as described previously
(reference 27). 1  g of each DNA sample was resolved in a 0.75% agarose
gel by field inversion gel electrophoresis (pulse conditions: 180 V for-
ward; 120 V reverse for 16 h). The gel was dried and the DNA hybrid-
ized to a 32P-end labeled telomeric oligomer overnight followed by 3   5
min washes at 37 C in 0.35  SSC buffer. Images were collected using a
Phosphor-Imager screen. Size of molecular weight standards (kilobases)
are shown on the left. REST, resting; STIM, anti-CD3/CD28 stimu-
lated. (B) The mean TRF length was calculated and averaged for all rest-
ing and stimulated T cell samples taken from a total of five adult mice and
seven secondary recipients. Error bars (standard deviation) and P values
(Student’s t test) are shown.
Figure 2. Analysis of telomerase activity in resting and stimulated do-
nor-derived T cells. (A) Splenic T cells (2   105) from young adult mice
and secondary HSC recipients were collected via FACS® and either lysed
in CHAPS buffer for extraction of telomerase, or transferred to growth
media for stimulation. After 2 d of growth, anti-CD3/CD28 stimulated
splenic T cells were harvested for extraction of telomerase. Telomerase
activity was measured for 500 cell equivalents of each sample extract by
the TRAP assay. (B) Telomerase activity was measured for resting
(REST) and stimulated (STIM) T cells from a total of five adult mice and
seven secondary recipients and averaged for all samples. The mean level of
activity and error bars (standard deviation) are shown. (C) Analysis of
TERT localization in resting and stimulated T cells. Resting and anti-
CD3/CD28 stimulated T cells from mTERT wild-type mice and resting
T cells from mTERT knockout mice were fixed and stained with an
mTERT antibody (top panel). Corresponding Hoechst 33258 staining for
each cell is also shown (bottom panel). Original magnification:  60.  
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the shorter TRF mode in T cells from secondary recipients
(unpublished data). To test for selection of T cells with a
long initial telomere length after stimulation, we costimu-
lated 10 pools of 9 T cells from transgenic mice which ex-
press GFP throughout the hematopoietic system, plus a sin-
gle donor-derived T cell from a secondary HSC recipient.
2 1/2 wk after stimulation, cells derived from the second-
ary HSC recipient T cell were isolated by FACS
 
®
 
 for FISH
analysis of telomere length (Fig. 4). For all pools containing
cells derived from the secondary recipient (6 of 10), telo-
mere signal intensity increased significantly (
 
 
 
50%), be-
coming approximately equal to that observed for resting T
cells from adult mice (Fig. 4 B). In addition, we also stimu-
lated 10 pools of 10 T cells from an independent secondary
HSC recipient and observed a similar increase in telomere
signal intensity in all pools (unpublished data). Thus, while
we cannot completely exclude the existence of a rare pop-
ulation of T cells with a long initial telomere length, the
increase in telomere length following stimulation of donor-
derived T cells from HSC transplant recipients is, at least in
part if not entirely, a direct result of extension of the short-
ened telomeres in these cells.
 
Discussion
 
Results from a number of studies have indicated that ex-
tension of telomere length can occur in normal somatic
cells. Lengthening of telomeres has been observed during
development in the offspring of mice in which the set of
telomeres inherited from one parent are longer than those
inherited from the other (37). Compared with adult tissues,
telomerase activity is relatively high in the germ line (15)
and the developing embryo (38, 39) including embryonic
stem cells (17) and therefore the increase in telomere length
observed in this study is likely telomerase dependent. Pre-
vious studies have also provided strong evidence for telo-
mere lengthening in B cells: germinal center (GC) B cells
have longer telomeres than either precursor naive B cells or
more mature memory B cells (40), and stimulation of mu-
rine splenocytes in vivo has been shown to be accompanied
by an increase in telomere length in wild-type mice but not
early generation (G1) mTR
 
 
 
/
 
 
 
 mice (41). However, the
selection of a rare subpopulation of B cells with an initial
long telomere length, as opposed to true extension of telo-
meres, was not ruled out in these studies. Here we show
that antigenic stimulation of T cells derived from serially
transplanted HSCs with an initial short telomere length di-
rectly results in a telomerase-dependent extension of telo-
mere length to a size roughly equal to that observed in T
cells from young animals.
Although we believe our data favors a scenario in which
telomere length is restored via a telomerase-dependent
mechanism in most if not all resting T cells that have ac-
quired shortened telomeres, other possible mechanisms
warrant discussion. One alternative explanation for the res-
toration of telomere length that we observe in stimulated T
cells from secondary HSC recipients is that HSCs and/or
resting T cells with increased levels of telomerase activity
are being selected for during transplantation or after stimu-
lation, respectively. However, we have compared telomer-
ase activity between HSCs isolated directly from donor an-
imals and from primary and secondary recipients, and
found no change in the level of activity with successive
rounds of transplantation (unpublished data). Furthermore,
we have previously shown that telomere length decreases
in HSCs during serial transplantation, which would not be
expected if cells with higher levels of telomerase were be-
ing selected for. Although we cannot rule out the possibil-
ity of selection of resting T cells with high initial levels of
telomerase, a mechanism to explain the inability of telom-
Figure 3. FISH analysis of telomere length in resting and stimulated
donor-derived T cells from transplant recipients of HSC from mTR
knockout mice. (A) Splenic T cells (5   104) from young adult mTR
wild-type or knock-out mice and secondary HSC recipients were col-
lected via FACS® and either transferred to growth media for stimulation
or fixed. 1 wk after anti-CD3/CD28 stimulation, cells were cytospun
onto glass slides and fixed. Telomeres were detected by FISH using a
FITC-conjugated peptide nucleic acid telomeric oligomer. Individual in-
terphase nuclei are indicated by arrowheads. Original magnification:  60.
The size scale ( m) is indicated in the bottom left. (B) The fluorescent te-
lomeric signal intensity was calculated and corrected for background for
20 well isolated individual resting or stimulated mTR /  or mTR /  do-
nor-derived splenic T cell nuclei. Telomeric signal intensity was also
measured for resting splenic T cells from an adult wild-type mouse. The
mean fluorescent signal intensity and standard deviation are shown. Telo-
meric signal intensity increased significantly (P   0.005; Student’s t test)
after stimulation of donor-derived splenic T cells from secondary recipi-
ents of mTR /  HSCs. 
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erase to restore telomere length in these cells before stimu-
lation would have to be presumed, as these cells almost cer-
tainly have a shortened telomere length before stimulation
(Fig. 4; see Results). Furthermore, it would also have to be
assumed that any T cells with higher levels of telomerase
would either have to be a rare population or be able to fur-
ther increase their levels of telomerase upon activation, as
telomerase activity increases dramatically following anti-
genic stimulation of T cells (32–35; Fig. 2). It is also possi-
ble that the telomerase-independent ALT (alternative
lengthening of telomeres) mechanism (42) for extending
telomeres may be contributing to the telomere elongation
in activated donor-derived T cells. The rate of telomere
length increase, 
 
 
 
7 kb over 16–17 d or
 
 
 
 
 
8–12 population
doublings, that we observe is relatively fast, akin to the
rapid increase in telomere length observed in ALT-positive
tumor cell lines (42). Also, after immunization, telomere
length in splenocytes from late generation (G5) mTR
 
 
 
/
 
 
 
mice have been observed to increase by
 
 
 
 
 
12 kb (41),
which may very well be explained by the previous activa-
tion of ALT in these mice. However, we have not ob-
served, in resting or activated T cells (Fig. 1 A), the large,
heterogeneous distribution of TRFs that is characteristic of
ALT-positive cells (42), nor have we observed an increase
in telomere length after activation of T cells from telomer-
ase-deficient mice (Fig. 3). Nevertheless, it will be of inter-
est to further assess the possible contribution of ALT to the
restoration of telomere length following activation of do-
nor-derived T cells.
The observations reported here suggest that one function
of telomerase in some or all subsets of T cells may be to re-
store telomere length upon antigenic stimulation in cells
that have acquired shortened telomeres. In agreement with
this notion is the positive correlation previously observed
between telomerase activity level and telomere length after
antigen stimulation of human CD4
 
 
 
 T cells (43). One con-
sequence of the ability to replenish telomere length in T
cells with short telomeres is a concomitant increase in rep-
licative capacity. This could perhaps be important not only
in any rare naive or memory T cells in young individuals
which may have acquired one or more critically short telo-
meres, but also in the elderly in which hematopoietic cells,
including T cells, have very short telomeres (25). Specifi-
cally, it may be possible for these cells, upon antigenic
stimulation in vivo, to thwart a premature replicative se-
nescence induced by further telomere shortening via the
regeneration of telomere length to a size observed in young
individuals. To confirm this, it will be necessary to assess
changes in telomere length after stimulation of T cells from
elderly individuals, or, if they can be identified, T cells with
short telomeres from young individuals.
As previously noted by Liu et al. (36) we find that
TERT, surprisingly, appears to be predominantly present
in the cytoplasm in resting T cells and translocates to the
nucleus after antigenic stimulation (Fig. 2 C). It is quite
likely that TERT translocation, as well as other events, are
essential for the activation of telomerase in stimulated T
cells. Although full details of the signaling mechanism lead-
ing to the nuclear translocation TERT have yet to be
worked out, it may involve association of TERT with 14–
3-3 proteins (44). The 14–3-3 family of signaling proteins
act as molecular chaperones and have been shown to asso-
Figure 4. FISH analysis of telomere
length after clonal stimulation of do-
nor-derived T cells. (A) Splenic T cells
were sorted into 10 pools of 10 cells, 9
cells from a H2K-GFP transgenic
mouse, and 1 cell of donor type from a
secondary HSC recipient, in growth
media in a 96-well V-bottomed dish
for stimulation. Resting splenic T cells
were also collected via FACS, cyto-
spun onto slides, and fixed at this time.
17 d after stimulation, T cells derived
from the secondary recipient (i.e.,
non-GFP cells) were collected via
FACS® from each stimulated pool in
which they could be detected, and ei-
ther cyto-spun onto glass slides, and
fixed or used for confirmation of T
cell functionality by TCR clonotype
analysis (reference 48; unpublished
data). The telomeres were detected by
FISH using a FITC-conjugated pep-
tide nucleic acid telomeric oligomer.
Individual interphase nuclei are indi-
cated by arrowheads. Sample images
of stained nuclei collected from resting splenic T cells (top panel) and of one clonal pool of anti-CD3/CD28 stimulated splenic T cells from a secondary
recipient (bottom panel) are shown. Original magnification:  60. The size scale ( m) is indicated in the bottom left. (B) The fluorescent telomeric signal
intensity was calculated and corrected for background for 20 well isolated individual resting or stimulated splenic T cell nuclei from a secondary recipient.
Telomeric signal intensity was also measured for resting and clonally stimulated splenic T cells (n   20 for each) from a C57Bl6/Ka Thy1.1 mouse. The
mean fluorescent signal intensity and standard deviation are shown. For all clonal expansions derived from T cells from the secondary HSC recipient, the
telomere signal intensity increased significantly relative to resting T cells from the same mouse (P   0.005; Student’s t test). 
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ciate with TERT (44). In addition, TERT contains a
NES-like motif in close proximity to the 14–3-3 binding
site, suggesting that the binding of 14–3-3 proteins to
TERT may inhibit the interaction of the exportin CRM1
with the TERT NES-like motif (44). The signaling mech-
anism for TERT translocation may also involve phosphor-
ylation of TERT (36). It will be of great interest to identify
all of the factors involved in the activation of TERT in
resting T cells, as these factors may perhaps provide a novel
target in therapies to treat T cell leukemias. It will also be
important to assess the physiologic significance of the local-
ization of TERT in the cytoplasm of resting T cells, and to
assess whether TERT is also localized in the cytoplasm of
other hematopoietic cells, including HSCs.
The data reported here suggests that telomerase can ex-
tend telomere length in T cells during the first few dou-
blings after stimulation, but only to a size equal to that ob-
served in resting T cells in young animals
 
.
 
 The mechanism
which limits the amount by which telomerase can extend
telomere length, although not well understood, may in-
volve the interaction of the newly assembled telomeric
chromatin with telomerase in a negative feedback loop.
One telomeric binding protein in particular that probably
has an important role in this feedback loop is the Myb-
related protein TRF1, which binds at numerous sites along
the telomeric DNA tract (45). Overexpression of TRF1 or
inhibition of its normal association with telomeric chroma-
tin leads to a decrease or increase in telomere length, re-
spectively (46). Furthermore, TRF1 induces bending in te-
lomeric DNA upon binding (47) which may in turn affect
the enzymatic activity of telomerase. Future in vivo studies
as to the effect of TRF1 function and expression on telo-
mere length maintenance in embryonic stem cells and germ
line cells, and telomere length rejuvenation in lympho-
cytes, should help shed more light on this subject.
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